ID

44019

Description

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00288379

Link

https://clinicaltrials.gov/show/NCT00288379

Keywords

Versions (2)
  1. 4/7/16 4/7/16 -
  2. 9/20/21 9/20/21 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT00288379

English

Eligibility Asthma NCT00288379

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00288379
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
a diagnosed history of asthma for at least 6 months
Description

asthma

Data type

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0040223
mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
Description

mild stable asthma only using β2-agonists

Data type

boolean

Alias
UMLS CUI [1,1]
C0741266
UMLS CUI [1,2]
C2945599
UMLS CUI [2]
C2936789
fev1 >70% of predicted normal value (post-bronchodilator value).
Description

fev1 post-bronchodilator

Data type

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C2599594
skin prick test positive to pollen, animal dander or house dust mite.
Description

skin prick test positive to pollen, animal dander or house dust mite

Data type

boolean

Alias
UMLS CUI [1,1]
C0430561
UMLS CUI [1,2]
C0323138
UMLS CUI [1,3]
C0440454
UMLS CUI [1,4]
C3539110
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any significant respiratory disease, other than asthma.
Description

respiratory disease

Data type

boolean

Alias
UMLS CUI [1]
C0035204
upper or lower respiratory tract infection within 4 weeks before inclusion.
Description

respiratory tract infection

Data type

boolean

Alias
UMLS CUI [1,1]
C0035243
UMLS CUI [1,2]
C0040223
use of:
Description

use of

Data type

boolean

Alias
UMLS CUI [1]
C1524063
1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
Description

inhaled steroid treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0556393
UMLS CUI [1,3]
C0006280
UMLS CUI [1,4]
C0040223
2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
Description

inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes

Data type

boolean

Alias
UMLS CUI [1]
C2936789
UMLS CUI [2]
C0354764
UMLS CUI [3]
C0019590
UMLS CUI [4]
C0039771
3. regular nsaids
Description

nsaids

Data type

boolean

Alias
UMLS CUI [1]
C0003211
Back to the top of the page

Similar models

Eligibility Asthma NCT00288379

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00288379
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
asthma
Item
a diagnosed history of asthma for at least 6 months
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
mild stable asthma only using β2-agonists
Item
mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
boolean
C0741266 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C2936789 (UMLS CUI [2])
fev1 post-bronchodilator
Item
fev1 >70% of predicted normal value (post-bronchodilator value).
boolean
C0748133 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
skin prick test positive to pollen, animal dander or house dust mite
Item
skin prick test positive to pollen, animal dander or house dust mite.
boolean
C0430561 (UMLS CUI [1,1])
C0323138 (UMLS CUI [1,2])
C0440454 (UMLS CUI [1,3])
C3539110 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
respiratory disease
Item
any significant respiratory disease, other than asthma.
boolean
C0035204 (UMLS CUI [1])
respiratory tract infection
Item
upper or lower respiratory tract infection within 4 weeks before inclusion.
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
use of
Item
use of:
boolean
C1524063 (UMLS CUI [1])
inhaled steroid treatment
Item
1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
boolean
C0001617 (UMLS CUI [1,1])
C0556393 (UMLS CUI [1,2])
C0006280 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes
Item
2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
boolean
C2936789 (UMLS CUI [1])
C0354764 (UMLS CUI [2])
C0019590 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
nsaids
Item
3. regular nsaids
boolean
C0003211 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial